ARTBIO develops innovative Alpha Radioligand Therapies (ARTs) using Pb-212 isotope technology to transform cancer care. Their proprietary AlphaDirect™ method enables distributed manufacturing, improving both accessibility and efficiency of treatment, while their lead program, AB001, is currently in first-in-human trials.
No jobs found
Try different keywords or remove some filters.
Or create a free account and we’ll email you when new jobs match what you’re looking for.
Create a free account
Searching